Crinetics shareholders elect three Class II directors, ratify PwC, approve say-on-pay

Crinetics Pharmaceuticals, Inc.

Elected Caren Deardorf (73.5M for), Weston Nichols (90.2M for), and Stephanie S. Okey (72.2M for) to 2029 terms.
Ratified PricewaterhouseCoopers LLP as independent auditor for FY2026: 101.7M for, 342K against, 12.7K abstain.
Advisory vote on named executive officer compensation approved: 91.7M for, 2.7M against, 2.6M abstain, 5.0M broker non-votes.
Approximately 97% of outstanding shares (102,030,415) were represented at the meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Crinetics Pharmaceuticals, Inc. shareholders approved Election of three Class II directors to the Board of Directors for three-year terms to expire at the 2029 annual meeting of stockholders. at the 2026-06-18 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-18

Exact text from the filing

The Company’s stockholders approved the election of three Class II directors to the Board of Directors for three-year terms to expire at the 2029 annual meeting of stockholders. The results of such vote were: Votes For Votes Withheld Broker Non-Votes Caren Deardorf 73,454,076 23,532,328 5,044,011 Weston Nichols, Ph.D. 90,208,564 6,777,840 5,044,011 Stephanie S. Okey, M.S. 72,225,313 24,761,091 5,044,011

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Crinetics Pharmaceuticals, Inc. shareholders approved Ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-18 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-18

Exact text from the filing

The Company’s stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of such vote were: Votes For Votes Against Abstentions 101,675,974 341,727 12,714

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Crinetics Pharmaceuticals, Inc. shareholders approved Approval, on an advisory basis, of the compensation of the Company’s named executive officers. at the 2026-06-18 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-18

Exact text from the filing

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The results of such vote were: Votes For Votes Against Abstentions Broker Non-Votes 91,657,992 2,698,538 2,629,874 5,044,011

View on SEC.gov

1183 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Crinetics Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001658247-26-000044

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.